Discovery & Preclinical Solutions for Life Sciences

Discovery & Preclinical

Contact

New strategies for drug discovery and development

Research and development is the lifeblood of every life sciences company and today, companies need to accelerate their discovery efforts.

Cognizant’s digital solutions are focused on improving your discovery and preclinical processes, and optimizing your product development strategies. Count on us to address the full discovery lifecycle with offerings that include re-engineering and consulting services, lab automation services, biomarker research and knowledge process outsourcing.

The result is faster drug discovery and better patient outcomes.

Learn more about our Life Sciences solutions for your business.

Re-engineering and consulting

Use preclinical processes and IT solutions to reimagine the entire discovery and research value chain.

Lab automation

A set of automation solutions that accelerate pharmaceutical research by simplifying operations and reducing manual tasks.

Biomarker research

Our data repositories, marker mining capabilities and pharmacogenomics help in the diagnosis and personalized treatment of diseases.

Decision-support systems

The next wave of business analytics is helping to meet customer needs faster than ever. Our decision-support systems include visual mining and informatics-driven drug discovery.

Research tools

Advanced research tools such as bioinformatics and chemoinformatics are enabling breakthroughs in areas such as genetic engineering and genomics.

Knowledge process outsourcing

Take advantage of additional tools like research and competitive intelligence reports and intellectual property reports.

Related thinking

Agile drug development required in a new age of urgency

It’s time to reconsider the current paradigm of drug development, clinical trials and regulatory approvals.

The future of infectious disease

For all its horrors, the COVID-19 pandemic may be the agent that takes us to a better place.

AI regulation is coming to life sciences: Three steps to take now

To maximize the value of artificial intelligence and machine learning for patients, healthcare providers together with life sciences enterprises must gear up to meet the continually evolving regulatory landscape.

SHOWCASE

Featured work

LIFE SCIENCES

AI keeps sensitive pharma information secure

LIFE SCIENCES

Data science fast-tracks cancer drug development

LIFE SCIENCES

Analytics helps improve regulatory compliance

LIFE SCIENCES MANAGEMENT

Leadership

Avi Kulkarni

SVP Life Sciences Strategic Business Unit Head

Gaurav Marya

Strategic Business Unit Head & Business Unit Integration Lead, Life Sciences

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.